Clinical trial
Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam…
NCT00446420 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00446420 |
|---|---|
| Title | Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations |
| Official title | Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations |
| Lead sponsor | Melbourne Health, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cognitive Impairment |
| Intervention type | Drug |
| Interventions | Propofol, midazolam, fentanyl |
| Enrollment | 200 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Mar 12, 2007 |
| Last update posted | May 30, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: